21 CFR 522.1066

§ 522.1066 Glycopyrrolate.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 522.1066, § 522.1066 Glycopyrrolate, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87454
Permanent ID: ys:prov:87454@1
SHA-256: 1547ed655fb34ea2fb3a9c779bb677641278c0dfb9d4029892380f8254c3fccf

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each milliliter of solution contains 0.2 milligram glycopyrrolate. (b) Sponsors. See Nos. 054771 and 069043 in § 510.600(c) of this chapter. (c) Conditions of use in dogs and cats—(1) Amount. 5 micrograms per pound of body weight (0.25 milliliter per 10 pounds of body weight) by intravenous, intramuscular, or subcutaneous injection in dogs or by intramuscular injection in cats. (2) Indications for use. As a preanesthetic agent. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.